Monitoring Tools & Notes

monitoring tools to save you time

Monitoring Tools and Notes As a regional monitor, I have primarily worked on studies with a conduct period of only a few months.  For these trials, I can typically monitor an entire subject’s source in just a couple of monitoring visits (IMVs).  However, I do use a few monitoring tools to keep me organized and…

Continue Reading →

3 Simple Ways to Improve the Approach

improve the approach in clinical trial services

I was invited to speak on a panel this week at the Outsourcing in Clinical Trials West Coast conference.  This was my second year in attendance and the conference was an excellent investment of my time with lots of great networking and informative sessions.  The topic for my panel was “Examining mistakes some vendors make…

Continue Reading →

Striving for Improved Investigator and Site Relationships

Last year I was invited to present at a conference in San Francisco; it was a wonderful experience. Here are this year’s conference details. 5th annual Outsourcing in Clinical Trials West Coast I was just organizing some files on my computer and came across the slidedeck, “Striving for improved Investigator and site relationships to achieve…

Continue Reading →

Improved Investigator and Site Relationships – Part II

This is a presentation I gave at the 4th annual Outsourcing in Clinical Trials conference in San Francisco in February of 2012. It has been posted in three parts: Click here to go back and review Part I  Read Part II below Part III – conclusion _________________________________________________________________ Support the sites in order to maximize subject enrollment…

Continue Reading →

Investigator and Site Relationships – Part III

This is the third and final portion of a presentation I delivered at a conference in February 2012 entitled: “Striving for improved Investigator and site relationships to achieve higher commitment and optimal patient numbers” Click here to go back and review Part I  Click here for a link back to Part II Read Part III…

Continue Reading →

Vacation Photos

The Lead CRA visits Schönbrunn Palace

I’ve just returned from a restful vacation in Vienna and Budapest.  I posted some photos here to share. Schönbrunn Palace was really beautiful! Budapest, Hungary Vienna, Austria I’m planning a few more clinical research related blog posts before the end of the year.  This has been an extremely rewarding year at work and we have been…

Continue Reading →

Happy Thanksgiving

happy thanksgiving to the Lead CRA blog readers

Today I am thankful for time with my family and my little dogs.  I am also extremely thankful for another rewarding and challenging year at work. I love my job and the team I work with make every day in the office interesting and fun.  Their reliability and focus on quality are unparalleled in any of my previous positions and I…

Continue Reading →

Site Startup Series

Welcome to The Lead CRA Blog Site Startup Series.  This course of blog posts is designed to step you through the various activities of launching a clinical trial site. What are the regulatory requirements before recruitment can begin? What are typical sponsor requirements? How do clinical trial sites even get chosen? These topics and more,…

Continue Reading →

Thinking About Site Startup

Clinical Study Site Startup. Ready to Enroll.

I’ve been thinking a lot lately about how important it is to choose the right clinical trial sites for the success of your trial.  Just last week I blogged about the painful process and high costs of closing non-performing or under-performing sites.  I recently told a non-industry friend that it can take upwards of 18 months sometimes to usher a clinical site…

Continue Reading →

Closing Non-Performing Sites

setting poor sites out to pasture

According to a 2009 study by Morrison and Pfizer, roughly 30% of sites that are opened fail to enroll.  Despite careful site selection criteria and thorough feasibility, dud sites are opened in most trials (although unintentionally and we do go to great measures to avoid this). In my career I have only worked on three studies…

Continue Reading →